SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure

Saved in:
Bibliographic Details
Main Authors: Pongsathorn Gojaseni, Jananya Wattanakul, Anan Chuasuwan, Anutra Chittinandana
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2373275
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849716843791515648
author Pongsathorn Gojaseni
Jananya Wattanakul
Anan Chuasuwan
Anutra Chittinandana
author_facet Pongsathorn Gojaseni
Jananya Wattanakul
Anan Chuasuwan
Anutra Chittinandana
author_sort Pongsathorn Gojaseni
collection DOAJ
format Article
id doaj-art-afd72aadc2034d3a9ee7b9349dc5bb13
institution DOAJ
issn 0886-022X
1525-6049
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-afd72aadc2034d3a9ee7b9349dc5bb132025-08-20T03:12:51ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146210.1080/0886022X.2024.2373275SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failurePongsathorn Gojaseni0Jananya Wattanakul1Anan Chuasuwan2Anutra Chittinandana3Division of Nephrology, Department of Medicine, Bhumibol Adulyadej Hospital, Directorate of Medical Services, Royal Thai Air Force, Bangkok, ThailandDivision of Nephrology, Department of Medicine, Bhumibol Adulyadej Hospital, Directorate of Medical Services, Royal Thai Air Force, Bangkok, ThailandDivision of Nephrology, Department of Medicine, Bhumibol Adulyadej Hospital, Directorate of Medical Services, Royal Thai Air Force, Bangkok, ThailandDivision of Nephrology, Department of Medicine, Bhumibol Adulyadej Hospital, Directorate of Medical Services, Royal Thai Air Force, Bangkok, Thailandhttps://www.tandfonline.com/doi/10.1080/0886022X.2024.2373275
spellingShingle Pongsathorn Gojaseni
Jananya Wattanakul
Anan Chuasuwan
Anutra Chittinandana
SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure
Renal Failure
title SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure
title_full SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure
title_fullStr SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure
title_full_unstemmed SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure
title_short SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure
title_sort sglt2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2373275
work_keys_str_mv AT pongsathorngojaseni sglt2inhibitordapagliflozinreducesproximaltubularcelldamagebiomarkersinpatientswithacuteheartfailure
AT jananyawattanakul sglt2inhibitordapagliflozinreducesproximaltubularcelldamagebiomarkersinpatientswithacuteheartfailure
AT ananchuasuwan sglt2inhibitordapagliflozinreducesproximaltubularcelldamagebiomarkersinpatientswithacuteheartfailure
AT anutrachittinandana sglt2inhibitordapagliflozinreducesproximaltubularcelldamagebiomarkersinpatientswithacuteheartfailure